Transparency of the cornea, our window to the world, and functionality of the neighbouring conjunctiva are critical for vision. Compromise of the various stem cells that maintain these tissues can lead to blindness. The Cells for Sight Team is aiming to understand the biology and therapeutic potential of stem cells (and the cells with which they interact) to develop and deliver novel cell-based therapies and anti-scarring strategies for patients with blinding corneal and conjunctival disease.
The Cells for Sight Stem Cell Therapy Research Unit is a MHRA licensed state-of-the-art GMP facility is available to internal and external researchers (academic and commercial) for the manufacture of Advanced Therapy Medicinal Products.
Read more about the Cell Therapy Unit